news
« BACK
Health - Administration - 27.04.2020 
Containment measures avoid 200,000 hospitalizations in Italy
Researchers have modeled the effects of containment and social distancing measures implemented by the Italian government to prevent the spread of COVID-19. Their findings show that contagion transmission was reduced by 45% in March. The model will now be used to analyze possible future scenarios. Since the beginning of the COVID-19 pandemic, mobility restrictions and social distancing measures implemented by the Italian government have avoided at least 200,000 hospitalizations and, over time, reduced contagion transmission by 45%.
Health - Pharmacology - 23.04.2020 
A new therapeutic target turns the immune system against lymphoma
EPFL scientists have identified a key mechanism that tumor cells use to take advantage of and avoid detection from the immune system. Targeting this mechanism offers a new therapeutic strategy for cancers like Non-Hodgkin lymphoma. Non-Hodgkin lymphoma (NHL) is a group of cancers that originate in the lymph nodes and affect white blood cells of the immune system called B cells.
Pharmacology - Health - 21.04.2020 
Into drugs and vaccines to combat Covid-19
As the world anxiously awaits a remedy for the novel coronavirus, ETH Zurich is also involved in the search for active substances and vaccines. This overview sets out the therapeutic approaches pursued by ETH researchers. As yet, there is still no reliable treatment for Sars-CoV-2. However, scientists across Switzerland and worldwide are engaged in an intensive search for an effective agent against the pathogen responsible for the Covid-19 pandemic.
Health - Life Sciences - 21.04.2020 
A new biosensor for the COVID-19 virus
A team of researchers from Empa, ETH Zurich and Zurich University Hospital has succeeded in developing a novel sensor for detecting the new coronavirus. In future it could be used to measure the concentration of the virus in the environment - for example in places where there are many people or in hospital ventilation systems.
Health - Pharmacology - 20.04.2020 
Towards a therapy against prostate cancer metastasis
An international group of researchers, led by the Institute of Oncology Research (IOR, affiliated to USI), has discovered a mechanism to recognise the cancer cells responsible for prostate cancer and selectively eliminate them. The study was published on April 6 by the Journal of Clinical Investigation (JCI).
Pharmacology - Health - 20.04.2020 
Novartis to sponsor clinical trial of hydroxychloroquine in COVID-19 patients
Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial of hydroxychloroquine in hospitalized patients with COVID-19 disease.
Health - Pharmacology - 17.04.2020 
Sleeping Sickness Elimination at a Crossroads
Human African trypanosomiasis, also known as HAT or sleeping sickness, is a vector-borne parasitic disease. Since the number of new cases reported between 2000 and 2018 dropped by 95%, the World Health Organization (WHO) targeted its elimination as a public health problem by 2020 and interruption of transmission (zero cases) for 2030; but there is still much work to be done.
Health - Life Sciences - 17.04.2020 
Analyses for getting to grips with the pandemic
ETH researchers are developing and improving methods to detect the pandemic virus or virus-specific antibodies. With the help of such tests, the scientists are also investigating the details of how the pathogen is spreading. A project overview. Even though the first wave of the COVID-19 pandemic has passed its peak in Switzerland, coronavirus diagnostic procedures are as important as ever.
Health - Life Sciences - 15.04.2020 
Certain immune cells have different jobs depending on the organ
Group 3 innate lymphoid cells are immune cells that function differently depending on the organ: in the intestines, they prevent certain immune responses, whereas in the spleen they stimulate them. Researchers from the University of Basel have discovered how signals from the surrounding tissue control this.
Health - Computer Science - 15.04.2020 
Artificial intelligence accelerates blood flow MRI
Imaging technology helps to detect cardiovascular diseases much earlier; however, precise examinations are still very time-consuming. Researchers from ETH and the University of Zurich have now presented a method that could greatly accelerate dynamic magnetic resonance imaging of blood flow. "Thanks to this innovation, quantitative magnetic resonance imaging could make tremendous progress," says Sebastian Kozerke, Professor of Biomedical Imaging at ETH and the University of Zurich.
Life Sciences - Health - 14.04.2020 
A new approach to improve biological control agents of agricultural pests
In a new study, researchers from the University of Bern developed an experimental approach that may be used to improve a wide range of organisms that rely on microbial symbionts to control insect pests. This approach opens up a new avenue for the improvement of biological control strategies towards a more sustainable, pesticide-free agriculture.
Health - Life Sciences - 08.04.2020 
A novel molecular target for particularly aggressive cancers
By deciphering how the FKBP10 protein facilitates lung cancer progression, UNIGE scientists are proposing an original therapeutic strategy. Three-dimensional lung (green) and tumors (red) and corresponding X-ray scans (black and white) at weeks 0, 6, and 12 after tumour onset (left: mouse with intact FKBP10; right: mouse with inhibition of FKBP10).
Health - 08.04.2020 
Measures are having an impact
The "lockdown light" decreed by the Swiss Federal Council has led to each person infected with Sars-CoV-2 going on to infect only one person on average instead of two or three prior to the lockdown, as calculations by a team from ETH Zurich have shown. This means the situation is stable, but the epidemic has yet to be contained.
Health - Environment - 03.04.2020 
Wastewater testing as a potential early warning system for waves of coronavirus
You were already collecting wastewater samples in Ticino weeks ago - why? Christoph Ort (environmental engineer): We have many years of experience in the measurement of illicit drugs in wastewater.
Health - Computer Science - 02.04.2020 
Software to enable secure data-sharing for hospitals
The MedCo system aims to facilitate medical research on pathologies - such as cancer and infectious diseases - by enabling secure computations on decentralized data. The unique software has recently been deployed at three Swiss hospitals. MedCo was first released in 2019 as the first operational system to protect sensitive patient data so that it can be used collectively for medical research.
Health - Life Sciences - 01.04.2020 
Blocking the Iron Transport Could Stop Tuberculosis
The bacteria that cause tuberculosis need iron to survive. Researchers at the University of Zurich have now solved the first detailed structure of the transport protein responsible for the iron supply. When the iron transport into the bacteria is inhibited, the pathogen can no longer grow. This opens novel ways to develop targeted tuberculosis drugs.
Media - Health - 30.03.2020
Health - 27.03.2020 
A device for the early detection of certain eyesight problems
EPFL researchers have developed a device that can zoom in on previously invisible cells at the back of the eye. The technology could be extremely useful for ophthalmologists, in particular for detecting age-related macular degeneration early and assessing new treatment options. There is renewed hope for people with eyesight problems such as age-related macular degeneration, or AMD.
Life Sciences - Health - 23.03.2020 
Stem Cells and Nerves Interact in Tissue Regeneration and Cancer Progression
Researchers at the University of Zurich show that different stem cell populations are innervated in distinct ways. Innervation may therefore be crucial for proper tissue regeneration. They also demonstrate that cancer stem cells likewise establish contacts with nerves. Targeting tumour innervation could thus lead to new cancer therapies.
Pharmacology - Health - 23.03.2020 
IOR lays the foundation for a new clinical trial against lymphomas
A study conducted by med. Francesco Bertoni at the Institute of Oncology Research ( IOR , affiliated to USI) has shown that a specific combination of drugs is a potentially winning strategy in the fight against lymphomas. The results obtained in the laboratory have enabled the researchers at the Istituto Oncologico della Svizzera italiana ( IOSI ) to develop a clinical study together with the Swiss Group for Clinical Cancer Research ( SAKK ).
Health
Results 61 - 80 of 721.
Researchers have modeled the effects of containment and social distancing measures implemented by the Italian government to prevent the spread of COVID-19. Their findings show that contagion transmission was reduced by 45% in March. The model will now be used to analyze possible future scenarios. Since the beginning of the COVID-19 pandemic, mobility restrictions and social distancing measures implemented by the Italian government have avoided at least 200,000 hospitalizations and, over time, reduced contagion transmission by 45%.
EPFL scientists have identified a key mechanism that tumor cells use to take advantage of and avoid detection from the immune system. Targeting this mechanism offers a new therapeutic strategy for cancers like Non-Hodgkin lymphoma. Non-Hodgkin lymphoma (NHL) is a group of cancers that originate in the lymph nodes and affect white blood cells of the immune system called B cells.
As the world anxiously awaits a remedy for the novel coronavirus, ETH Zurich is also involved in the search for active substances and vaccines. This overview sets out the therapeutic approaches pursued by ETH researchers. As yet, there is still no reliable treatment for Sars-CoV-2. However, scientists across Switzerland and worldwide are engaged in an intensive search for an effective agent against the pathogen responsible for the Covid-19 pandemic.
A team of researchers from Empa, ETH Zurich and Zurich University Hospital has succeeded in developing a novel sensor for detecting the new coronavirus. In future it could be used to measure the concentration of the virus in the environment - for example in places where there are many people or in hospital ventilation systems.
An international group of researchers, led by the Institute of Oncology Research (IOR, affiliated to USI), has discovered a mechanism to recognise the cancer cells responsible for prostate cancer and selectively eliminate them. The study was published on April 6 by the Journal of Clinical Investigation (JCI).
Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial of hydroxychloroquine in hospitalized patients with COVID-19 disease.
Human African trypanosomiasis, also known as HAT or sleeping sickness, is a vector-borne parasitic disease. Since the number of new cases reported between 2000 and 2018 dropped by 95%, the World Health Organization (WHO) targeted its elimination as a public health problem by 2020 and interruption of transmission (zero cases) for 2030; but there is still much work to be done.
ETH researchers are developing and improving methods to detect the pandemic virus or virus-specific antibodies. With the help of such tests, the scientists are also investigating the details of how the pathogen is spreading. A project overview. Even though the first wave of the COVID-19 pandemic has passed its peak in Switzerland, coronavirus diagnostic procedures are as important as ever.
Group 3 innate lymphoid cells are immune cells that function differently depending on the organ: in the intestines, they prevent certain immune responses, whereas in the spleen they stimulate them. Researchers from the University of Basel have discovered how signals from the surrounding tissue control this.
Imaging technology helps to detect cardiovascular diseases much earlier; however, precise examinations are still very time-consuming. Researchers from ETH and the University of Zurich have now presented a method that could greatly accelerate dynamic magnetic resonance imaging of blood flow. "Thanks to this innovation, quantitative magnetic resonance imaging could make tremendous progress," says Sebastian Kozerke, Professor of Biomedical Imaging at ETH and the University of Zurich.
In a new study, researchers from the University of Bern developed an experimental approach that may be used to improve a wide range of organisms that rely on microbial symbionts to control insect pests. This approach opens up a new avenue for the improvement of biological control strategies towards a more sustainable, pesticide-free agriculture.
By deciphering how the FKBP10 protein facilitates lung cancer progression, UNIGE scientists are proposing an original therapeutic strategy. Three-dimensional lung (green) and tumors (red) and corresponding X-ray scans (black and white) at weeks 0, 6, and 12 after tumour onset (left: mouse with intact FKBP10; right: mouse with inhibition of FKBP10).
The "lockdown light" decreed by the Swiss Federal Council has led to each person infected with Sars-CoV-2 going on to infect only one person on average instead of two or three prior to the lockdown, as calculations by a team from ETH Zurich have shown. This means the situation is stable, but the epidemic has yet to be contained.
You were already collecting wastewater samples in Ticino weeks ago - why? Christoph Ort (environmental engineer): We have many years of experience in the measurement of illicit drugs in wastewater.
The MedCo system aims to facilitate medical research on pathologies - such as cancer and infectious diseases - by enabling secure computations on decentralized data. The unique software has recently been deployed at three Swiss hospitals. MedCo was first released in 2019 as the first operational system to protect sensitive patient data so that it can be used collectively for medical research.
The bacteria that cause tuberculosis need iron to survive. Researchers at the University of Zurich have now solved the first detailed structure of the transport protein responsible for the iron supply. When the iron transport into the bacteria is inhibited, the pathogen can no longer grow. This opens novel ways to develop targeted tuberculosis drugs.
Four keywords to understand journalism during a pandemic
From newspapers to television, from the internet to social media, we experience an overload of information on the Covid-19 pandemic. Science journalism has become an important source to help individuals understand what is true and what is false. In this video Philip Di Salvo, a post-doc researcher at USI Institute of Media and Journalism, proposes four key words to comprehend what is happening to the media.
From newspapers to television, from the internet to social media, we experience an overload of information on the Covid-19 pandemic. Science journalism has become an important source to help individuals understand what is true and what is false. In this video Philip Di Salvo, a post-doc researcher at USI Institute of Media and Journalism, proposes four key words to comprehend what is happening to the media.
EPFL researchers have developed a device that can zoom in on previously invisible cells at the back of the eye. The technology could be extremely useful for ophthalmologists, in particular for detecting age-related macular degeneration early and assessing new treatment options. There is renewed hope for people with eyesight problems such as age-related macular degeneration, or AMD.
Researchers at the University of Zurich show that different stem cell populations are innervated in distinct ways. Innervation may therefore be crucial for proper tissue regeneration. They also demonstrate that cancer stem cells likewise establish contacts with nerves. Targeting tumour innervation could thus lead to new cancer therapies.
A study conducted by med. Francesco Bertoni at the Institute of Oncology Research ( IOR , affiliated to USI) has shown that a specific combination of drugs is a potentially winning strategy in the fight against lymphomas. The results obtained in the laboratory have enabled the researchers at the Istituto Oncologico della Svizzera italiana ( IOSI ) to develop a clinical study together with the Swiss Group for Clinical Cancer Research ( SAKK ).
